Navigation Links
Shire's New Product Portfolio Delivers Strong Quarterly Performance
Date:10/29/2008

rket.

Pipeline Highlights

FIRAZYR - HAE

- Jerini received a not approvable letter for FIRAZYR for use in the US

from the US Food and Drug Administration ("FDA") in April 2008, and

plans to provide a complete response by the end of the year.

JUVISTA(R) - Improvement of scar appearance

- Renovo Limited ("Renovo") intends to initiate its first pivotal

European Phase 3 trial in scar revision in the fourth quarter of 2008

in support of Renovo's filing of a European regulatory dossier. If the

outcome from Renovo's multi centre, EU Phase 3 study is suitably

positive, the data will be used to inform the strategy and design of

Shire's US development plan and to strengthen the chances of regulatory

and commercial success in the US.

METAZYM (HGT-1111) - Metachromatic Leukodystrophy ("MLD")

- Shire has an ongoing enzyme replacement therapy program for the

treatment of MLD, which is a lysosomal storage disorder that results

from a deficiency in the enzyme arylsulfatase-A ("ASA"). METAZYM, a

clinical candidate ASA acquired from Zymenex in the second quarter of

2008, has completed a Phase 1b clinical trial in 12 MLD patients in

Europe and an extension to this study is ongoing. The product has been

granted orphan drug designation in the US and in the EU. The current

plan is to initiate a Phase 2/3 clinical trial as soon as possible

following discussions with regulatory authorities in Q4 2008.

Business Highlights

Acquisition of Jerini

- During Q3 2008 Shire acquired a majority voting interest in Jerini and

published an Offer Document in respect of acquiring the remaining

shares in Jerini that it did not already own. By September 30, 2008

Shire had acquired over 90% of the shares in Jerini and now owns

approximately 93% of the shares. The acquisition has
'/>"/>

SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
2. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
3. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
4. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
5. Consumers Looking to Sustainable Food Production to Feed Global Population
6. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
7. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
8. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
9. Ventria Expands Lactoferrin Production
10. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
11. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. ... company focused on advanced wound care, announces that ... tissues, have been added to the Premier, Inc. ... the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... on ... HeartMate II(R), PLEASANTON, Calif., Oct. 30 Thoratec,Corporation (Nasdaq: ... therapies to save, support and restore failing hearts,today said that ... revenues in the same period a year ago., Revenues ...
... (Nasdaq: ANDS ) announced today that it has ... virus (HCV) in Part B of a,two-part protocol designed ... ANA773 is the Company,s investigational oral TLR7 agonist,prodrug. In ... cohort will receive,800 mg of ANA773 every other day ...
... 30 In a joint press conference,Orange Romania ... cellular e-health service., "Health is the fundamental ... why,Orange and Medic4all are launching together the Medic4you ... Services Development,Manager for Orange Romania., Medic4you is ...
Cached Biology Technology:Thoratec Reports 44 Percent Increase in Third Quarter Revenues 2Thoratec Reports 44 Percent Increase in Third Quarter Revenues 3Thoratec Reports 44 Percent Increase in Third Quarter Revenues 4Thoratec Reports 44 Percent Increase in Third Quarter Revenues 5Thoratec Reports 44 Percent Increase in Third Quarter Revenues 6Thoratec Reports 44 Percent Increase in Third Quarter Revenues 7Thoratec Reports 44 Percent Increase in Third Quarter Revenues 8Thoratec Reports 44 Percent Increase in Third Quarter Revenues 9Thoratec Reports 44 Percent Increase in Third Quarter Revenues 10Thoratec Reports 44 Percent Increase in Third Quarter Revenues 11Thoratec Reports 44 Percent Increase in Third Quarter Revenues 12Thoratec Reports 44 Percent Increase in Third Quarter Revenues 13Thoratec Reports 44 Percent Increase in Third Quarter Revenues 14Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 2Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 3Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 4Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 5Orange and Medic4all Launched the World's First Cellular Tele-Health Service 2
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides ... and fingerprinting markets. Watermarking aims to control and ...
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, today announced ... genetic ancestry of individuals from across the United ... than four hundred years ago, the United States ... from different continents. This study illuminates how American history and ...
(Date:12/17/2014)... 2014  HITLAB SM announced today its completion of ... adherence to current U.S. Food and Drug Administration (FDA) ... device and smart phone application trials utilizing the highest ... "HITLAB is determined to improve global healthcare access, quality, ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... vegetable juice a daily habit could be a small ... daily vegetable recommendations, according to a new study being ... week at the American Dietetic Association annual conference 1 ... short of the daily recommended vegetable intake as put ...
... 23 Paradigm Tactical,Products Inc. (Pink Sheets: PDGT.PK), ... solutions to the military as well as to,the ... agreement,which will make the company the largest distributor ... and four additional detector models in,the United States. ...
... when raised on low calorie diets. But now researchers at ... that they can extend the life spans of roundworms even ... a chemical that blocks their sense of smell. Three ... reported they found that a class of anticonvulsant medications made ...
Cached Biology News:New study shows drinking your vegetables may be a solution to bridging the vegetable gap 2Paradigm Tactical Products to be Largest Distributor of Metal/Radiation Detection Wands in United States 2Paradigm Tactical Products to be Largest Distributor of Metal/Radiation Detection Wands in United States 3Deprived of a sense of smell, worms live longer 2
... biologic production demands on cell and tissue ... cell populations. Therefore, both cell concentration and ... accurately and precisely. The new Vi-CELLTM Cell ... effective means to perform the trypan blue ...
... is a post-translational modification that plays ... including immune regulation, inflammation, cell-to-cell adhesion, ... developed two lectin based Glycoprotein Isolation ... Germ Agglutinin (WGA), that allow isolation ...
... a powerful yet simple technology for labeling ... kit provides the heterobifunctional linkers SFB and ... efficiencies. It enables conjugation of various tags ... with a variety of proteins. , ...
... LS series of laser scanners is the ... Suite solution. ,Gene expression analysis, SNP ... essential to the advancement of research ... to novel microarray formats and sizes. These ...
Biology Products: